drugset / Trial / NCT06410859
Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal Neuralgia
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy of different dosing regimens of Botulinum Toxin Type A for Injection (HengLi®) in the treatment of trigeminal neuralgia (TN), so as to determine the optimal dosing regimen of the best administration scheme of Botulinum Toxin Type A for Injection (HengLi®) in the treatment of TN.
Timeline
- Start
- 2024-04-25
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 2.5 unknown | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 5 unknown | — |